Mark T Kearney Selected Research

Mark T Kearney Research Topics

Disease

30	Insulin Resistance 12/2022 - 01/2002
23	Heart Failure 10/2022 - 08/2003
15	Atherosclerosis 01/2020 - 10/2004
13	Type 2 Diabetes Mellitus (MODY) 01/2020 - 10/2004
12	Obesity 12/2022 - 04/2005
8	Left Ventricular Dysfunction 09/2019 - 07/2011
7	Inflammation (Inflammations) 01/2022 - 08/2005
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 08/2007
5	Vascular Diseases (Vascular Disease) 01/2019 - 12/2010
4	Infections 10/2022 - 01/2020
4	Ischemia 01/2021 - 11/2014
4	Diabetes Mellitus 12/2020 - 05/2012
4	Coronary Artery Disease (Coronary Atherosclerosis) 02/2008 - 10/2006
3	Chronic Obstructive Pulmonary Disease (COPD) 12/2020 - 10/2018
3	Atrial Fibrillation 10/2018 - 05/2004
3	Myocardial Infarction 01/2018 - 02/2013
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2005 - 11/2002
2	Weight Gain 12/2022 - 01/2019
2	Fibrosis (Cirrhosis) 01/2020 - 07/2017
2	Dyslipidemias (Dyslipidemia) 11/2014 - 10/2009
2	Hypertension (High Blood Pressure) 10/2009 - 08/2005
2	Ventricular Tachycardia 08/2003 - 11/2002
1	Hyperinsulinism (Hyperinsulinemia) 12/2022
1	Cardiovascular Infections 01/2022
1	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2021
1	Vascular Remodeling 11/2021
1	COVID-19 01/2021
1	Sudden Death 12/2020
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2020
1	Bradycardia 01/2019
1	Fatty Liver 12/2018
1	Sepsis (Septicemia) 10/2018
1	Infarction (Infarctions) 07/2017

Drug/Important Bio-Agent (IBA)

18	Insulin (Novolin)FDA Link 11/2021 - 04/2005
12	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 10/2004
8	Insulin ReceptorIBA 11/2021 - 11/2007
6	Insulin-Like Growth Factor I (IGF-1)IBA 12/2022 - 03/2008
6	Apolipoproteins E (ApoE)IBA 01/2020 - 05/2010
6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 08/2005
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2022 - 08/2003
5	Superoxides (Superoxide)IBA 01/2020 - 11/2007
5	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020 - 04/2008
5	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2013 - 04/2005
4	C-Reactive ProteinIBA 01/2022 - 08/2007
4	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2021 - 08/2011
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 05/2012
4	Insulin-Like Growth Factor Binding Protein 1IBA 01/2020 - 03/2008
4	CreatinineIBA 07/2017 - 11/2002
3	LipidsIBA 12/2022 - 08/2005
3	ApolipoproteinsIBA 01/2020 - 05/2010
2	insulin receptor-related receptor (IRR)IBA 01/2022 - 01/2021
2	AldosteroneIBA 01/2020 - 07/2017
2	Insulin-Like Growth Factor Binding ProteinsIBA 01/2020 - 03/2008
2	hydroxide ionIBA 09/2019 - 06/2016
2	Insulin-Like PeptidesIBA 01/2019 - 04/2012
2	Vitamin D FDA LinkGeneric 10/2018 - 06/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 08/2007
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2014 - 08/2007
2	Protein Isoforms (Isoforms)IBA 06/2013 - 04/2008
2	Insulin-Like Growth Factor Binding Protein 2IBA 05/2009 - 02/2007
2	Carrier Proteins (Binding Protein)IBA 03/2008 - 02/2007
2	Acetylcholine (Acetylcholine Chloride)FDA Link 08/2007 - 04/2005
2	SodiumIBA 08/2003 - 11/2002
1	cixutumumabIBA 12/2022
1	Mineralocorticoid Receptor AntagonistsIBA 10/2022
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 10/2022
1	Angiotensin Receptor AntagonistsIBA 10/2022
1	Retinaldehyde (Retinal)IBA 11/2021
1	AngiopoietinsIBA 11/2021
1	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 12/2020
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2020
1	superoxide dismutase 2IBA 01/2020
1	Serum AlbuminIBA 01/2020
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020
1	25-hydroxyvitamin DIBA 09/2019
1	Ion Channels (Ion Channel)IBA 01/2019
1	AdiponectinIBA 01/2019
1	Natriuretic PeptidesIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 12/2018
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018
1	IvabradineIBA 01/2018
1	GadoliniumIBA 01/2018
1	Troponin T (Troponin T1)IBA 07/2017
1	ReninIBA 07/2017
1	AngiotensinsIBA 07/2017
1	AlbuminsIBA 07/2017
1	Tyrosine (L-Tyrosine)FDA Link 03/2017
1	Nitric Oxide Synthase (NO Synthase)IBA 03/2017

Therapy/Procedure

20	Therapeutics 10/2022 - 05/2004
3	Defibrillators (Defibrillator) 12/2020 - 01/2016
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 12/2020 - 01/2016
2	Cardiac Resynchronization Therapy 12/2017 - 11/2013
2	Secondary Prevention 10/2009 - 02/2008
2	Glycemic Control 09/2008 - 11/2007
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2008 - 08/2007
1	Cardiopulmonary Resuscitation (CPR) 01/2021
1	Patient Readmission 01/2020
1	Artificial Pacemaker 01/2019
1	Catheter Ablation 10/2018